31.82
BATS BZX Real-Time Price
As of 12:31pm ET
 +0.92 / +2.98%
Today’s Change
27.88
Today|||52-Week Range
44.56
-18.79%
Year-to-Date
4 Reasons Drug Stocks Are a Buy Right Now
10:16am / MotleyFool.com - Paid Partner Content
For Gilead, Its Coronavirus Treatment Is Icing on the Cake
Mar 27 / MotleyFool.com - Paid Partner Content
These 2 Stocks Are Trading at a Once-in-a-Lifetime Price
9:04am / MotleyFool.com - Paid Partner Content
Coronavirus Pandemic Puts Upjohn-Mylan Megamerger on Hold
Mar 26 / MotleyFool.com - Paid Partner Content
Sanofi and Translate Bio Team Up to Work on a Coronavirus Vaccine
Mar 27 / MotleyFool.com - Paid Partner Content
3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?
Mar 26 / MotleyFool.com - Paid Partner Content
Is Bristol Myers Squibb Stock a Buy?
Mar 27 / MotleyFool.com - Paid Partner Content
3 Reasons Pharma Stocks Are a Buy Right Now
Mar 25 / MotleyFool.com - Paid Partner Content
2 Dividend Stocks Trading at Dirt-Cheap Prices
Mar 27 / MotleyFool.com - Paid Partner Content
3 Stocks You Don't Realize You Use Every Day
Mar 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close30.90
Today’s open31.09
Day’s range31.08 - 32.09
Volume8,927,879
Average volume (3 months)28,189,835
Market cap--
Data as of 12:31pm ET, 03/30/2020

Growth & Valuation

Earnings growth (last year)+53.85%
Earnings growth (this year)-14.89%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-3.54%
P/E ratio11.0
Price/Sales4.30
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+2.14+2.70%
MRKMerck+4.09+5.70%
LLYEli Lilly and Co+5.95+4.44%
BMYBristol-Myers Squibb+1.60+3.03%
Data as of 12:31pm ET, 03/30/2020

Financials

Next reporting dateApril 28, 2020
EPS forecast (this quarter)$0.70
Annual revenue (last year)$51.8B
Annual profit (last year)$16.3B
Net profit margin31.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts